A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...

A vast search of natural diversity has led scientists at MIT's McGovern Institute and the Broad Institute of MIT and Harvard ...

Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

Scientists from the University of Cologne identified the 1N4R tau isoform as a key contributor to neuronal dysfunction in ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR technologies in the field of ...

The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to antiviral therapies and diagnostics. However, to safely harness their powers, ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

A recent study by the University of Cologne has illuminated a specific tau protein's role in the progression of Alzheimer's ...

CAMBRIDGE, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...